Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake

被引:31
作者
Benvenga, S [1 ]
Lakshmanan, M [1 ]
Trimarchi, F [1 ]
机构
[1] Univ Messina, Sch Med, Cattedra Endocrinol, Messina, Italy
关键词
D O I
10.1089/thy.2000.10.1043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carnitine (3-hydroxy-4N-trimethylammoniumbutanoate) is a naturally occurring quaternary amine that is ubiquitous in mammalian tissues (concentrations in the order of mM). Based on limited studies of approximately 40 years ago, carnitine was considered to be a peripheral antagonist of thyroid hormone (TH) action. These interesting observations have not been explored. To study the biologic basis of this effect, we tested the following possibilities in three TH-responsive cell lines: (1) inhibition of TH entry into cells; (2) inhibition of TH entry into the nucleus; (3) inhibition of TH interaction with the isolated nuclei; and (4) facilitated efflux of TH from cells. On a preliminary basis we had verified that these cell Lines (human skin fibroblasts, human hepatoma cells HepG2, and mouse neuroblastoma cells NE 41A3) take up (14C)carnitine; however, there was no (14C)carnitine uptake into the nuclei. Concentrations of unlabeled carnitine as high as 100 mM did not affect (125I)T3 binding to isolated nuclei or exit of TH from cells, thus excluding possibilities numbered 3 and 4. At 10 mM carnitine, (125I)T3 and (125I)T4 whole-cell uptake was inhibited by approximately 20% in fibroblasts and in HepG2, but by approximately 5% in NE 41A3 cells. Inhibition of T3 nuclear uptake was evaluated in HepG2 and NE 41A3 cells. At 10 mM carnitine, inhibition of T3 nuclear uptake was disproportionately higher, namely approximately 25% in neurons and 35% in hepatocytes. At 50 mM carnitine, there was a minimal additional decrease in whole-cell uptake of either hormone but a marked decrease in T3 nuclear uptake. The latter inhibition was approximately 60% in neurons and 70% in hepatocytes. We are aware of no inhibitor of TH uptake that has such a markedly different effect on the nuclear versus whole-cell uptake. Our data are consistent with carnitine being a peripheral antagonist of TH action, and they indicate a site of inhibition at or before the nuclear envelope.
引用
收藏
页码:1043 / 1050
页数:8
相关论文
共 42 条
[21]   SPECIFIC BINDING PROTEINS OF THYROXINE AND TRIIODOTHYRONINE IN LIVER SOLUBLE PROTEINS [J].
HAMADA, S ;
TORIZUKA, K ;
MIYAKE, T ;
FUKASE, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1970, 201 (03) :479-&
[22]  
HELLTHALER G, 1967, ACTA BIOL MED GER, V19, P641
[23]   THE UPTAKE OF CARNITINE BY SLICES OF RAT CEREBRAL-CORTEX [J].
HUTH, PJ ;
SCHMIDT, MJ ;
HALL, PV ;
FARIELLO, RG ;
SHUG, AL .
JOURNAL OF NEUROCHEMISTRY, 1981, 36 (02) :715-723
[24]  
HUTSON SM, 1977, J BIOL CHEM, V252, P1309
[25]   NUCLEAR THYROID-HORMONE RECEPTORS IN CULTURED HUMAN-FIBROBLASTS - IMPROVED METHOD OF ISOLATION, PARTIAL CHARACTERIZATION, AND INTERACTION WITH CHROMATIN [J].
ICHIKAWA, K ;
DEGROOT, LJ ;
REFETOFF, S ;
HORWITZ, AL ;
POLLAK, ER .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (09) :861-868
[26]   MEMBRANE IODOTHYRONINE TRANSPORTERS .1. REVIEW OF PHYSIOLOGY [J].
KRAGIE, L .
ENDOCRINE RESEARCH, 1994, 20 (04) :319-341
[27]   BENZODIAZEPINES INHIBIT TEMPERATURE-DEPENDENT-L-[I-125] TRIIODOTHYRONINE ACCUMULATION INTO HUMAN LIVER, HUMAN NEUROBLAST, AND RAT PITUITARY CELL-LINES [J].
KRAGIE, L ;
DOYLE, D .
ENDOCRINOLOGY, 1992, 130 (03) :1211-1216
[28]   THE TRANSPORT OF THYROXINE INTO MOUSE NEUROBLASTOMA-CELLS, NB41A3 - THE EFFECT OF L-SYSTEM AMINO-ACIDS [J].
LAKSHMANAN, M ;
GONCALVES, E ;
LESSLY, G ;
FOTI, D ;
ROBBINS, J .
ENDOCRINOLOGY, 1990, 126 (06) :3245-3250
[29]   DIFFERENTIAL EFFECT OF A NEW THYROMIMETIC ON TRIIODOTHYRONINE TRANSPORT INTO MYOBLASTS AND HEPATOMA AND NEUROBLASTOMA-CELLS [J].
LAKSHMANAN, M ;
GONCALVES, E ;
PONTECORVI, A ;
ROBBINS, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1133 (02) :213-217
[30]   URINARY-EXCRETION OF CARNITINE IN PATIENTS WITH HYPERTHYROIDISM AND HYPOTHYROIDISM - AUGMENTATION BY THYROID-HORMONE [J].
MAEBASHI, M ;
KAWAMURA, N ;
SATO, M ;
IMAMURA, A ;
YOSHINAGA, K ;
SUZUKI, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (04) :351-356